Dr Rebecca Mccrackan
Director
Infectious Diseases
Epichem
Australia
Biography
Rebecca has over 15 years experience in the life science and resource sectors, presently working as Senior Intellectual Property Advisor for the global mining and metals group Rio Tinto. Rebecca’s intellectual property (IP) law experience spans traditional IP roles in private practice as a patent and trade marks attorney, research and development, and innovation deployment programmes. Rebecca has experience with both in-licensing and out-licensing of technologies, global IP strategies for a wide range of technologies and a comprehensive understanding of the IP and legal frameworks that underpin the successful commercialisation of innovation. Rebecca obtained a first class honours degree in biotechnology from Murdoch University and holds a PhD in biomedicine, undertaken at the Walter and Eliza Hall Institute of Medical Research, having spent a further two years as a postdoctoral scientist at the Spanish National Cancer Research Centre. Rebecca is a Registered Patent and Trade Marks Attorney, holds a Masters in Intellectual Property, is a fellow of the Australian Institute of Patent and Trade Mark Attorneys, a member of the Australian Institute of Company Directors and Intellectual Property Society of Australia and New Zealand. She is also a member of the Advisory Board for the Curtin Health Innovation Research Institute.
Research Interest
Rebecca has over 15 years experience in the life science and resource sectors, presently working as Senior Intellectual Property Advisor for the global mining and metals group Rio Tinto. Rebecca’s intellectual property (IP) law experience spans traditional IP roles in private practice as a patent and trade marks attorney, research and development, and innovation deployment programmes. Rebecca has experience with both in-licensing and out-licensing of technologies, global IP strategies for a wide range of technologies and a comprehensive understanding of the IP and legal frameworks that underpin the successful commercialisation of innovation. Rebecca obtained a first class honours degree in biotechnology from Murdoch University and holds a PhD in biomedicine, undertaken at the Walter and Eliza Hall Institute of Medical Research, having spent a further two years as a postdoctoral scientist at the Spanish National Cancer Research Centre. Rebecca is a Registered Patent and Trade Marks Attorney, holds a Masters in Intellectual Property, is a fellow of the Australian Institute of Patent and Trade Mark Attorneys, a member of the Australian Institute of Company Directors and Intellectual Property Society of Australia and New Zealand. She is also a member of the Advisory Board for the Curtin Health Innovation Research Institute.